<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical and pathological features of acquired <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>)-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, including their relationship with other viruses, such as Epstein-Barr virus (EBV) and human <z:e sem="disease" ids="C0019340" disease_type="Disease or Syndrome" abbrv="">herpes</z:e> virus-8 (HHV8), have been the subject of several studies from North America and Europe </plain></SENT>
<SENT sid="1" pm="."><plain>No consistent data have been reported in Africa, where <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> runs an epidemiological and clinical course different from that observed in Western countries </plain></SENT>
<SENT sid="2" pm="."><plain>We retrospectively evaluated the presence of human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV), HHV8, and EBV in 146 cases of malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> collected in Kenya (Equatorial Africa), with the use of polymerase chain reaction (PCR) and in situ hybridization (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>The PCR technique confirmed <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> in 16 HIV-seropositive subjects (11%) and showed the presence of HIV sequences in five additional cases (3%) in which the occurrence of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was the only clinical manifestation </plain></SENT>
<SENT sid="4" pm="."><plain>Our findings suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are not pathogenetically homogenous, and different mechanisms may contribute to <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> in these severely immunocompromised patients </plain></SENT>
<SENT sid="5" pm="."><plain>In our series, no association of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) with <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> could be shown </plain></SENT>
<SENT sid="6" pm="."><plain>Among non-HIV-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, EBV was present in 94% of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) occurring in patients younger than 15 years of age, in 87% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> independently of age, sex, and histological types, in 60% of anaplastic large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>), and to a lesser extent (13%) in large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (LBCL) cases </plain></SENT>
<SENT sid="7" pm="."><plain>Only one <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, a case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>, showed HHV8 by PCR </plain></SENT>
</text></document>